opti-ox deterministic cell programming to enable the industrialisation of New Approach Methodologies

You will learn:

• opti-ox technology enables deterministic manufacturing of human iPSC-derived cells, overcoming the inconsistency and heterogeneity of traditional directed differentiation to produce scalable, functional batches of human cells (ioCells)

• ioCells provide the standardised human cellular components necessary for the industrialisation of New Approach Methodologies (NAMs), offering the consistency required by both the pharmaceutical industry and regulatory agencies

• Advanced engineering avenues, including CRISPR-Ready and ioDisease Model Cells, allow for high-throughput genomic screens and the study of specific disease mechanisms within a highly controlled, consistent manufacturing workflow